New combination therapy now reimbursed for Aussies living with incurable blood cancer

By VIVA! Communications | June 2, 2020

Yesterday, VIVA! partnered with Celgene, a Bristol-Myers Squibb company and Myeloma Australia to announce the listing of REVLIMID® (lenalidomide) in combination with bortezomib (Velcade) and dexamethasone (RVd) on the Pharmaceutical Benefits Scheme (PBS). Australians living with the incurable blood cancer, multiple myeloma now have access to this new treatment option. The three drug regimen will…

Read More

Infectious diseases expert issues public health warning to avoid secondary surge in COVID-19

By Team VIVA! | May 15, 2020

This week, VIVA! Communications’ Principal and owner, Kirsten Bruce, Sydney spoke with internationally renowned Infectious Diseases Paediatrician and Immunisation expert, Professor Robert Booy, Sydney. They discussed the impact of COVID-19 on Australians to date, its potential implications moving forward, and the barriers facing scientists in their race to develop a vaccine. The rapid and effective…

Read More

Top tips for WFH video calls

By VIVA! Communications | April 30, 2020

How to avoid faux pas & respect your fellow zoomies Working from home presents unique challenges and opportunities for those fortunate enough to be able to do so. Businesses and their employees are doing their best to navigate these unprecedented times, so it’s important to practice patience and respect. Here at VIVA! we are doing…

Read More

What’s in a name? Coining history’s deadliest pandemics

By VIVA! Communications | April 20, 2020

Here’s some scientific nomenclature to help kick-start your Monday! For centuries before the advent of coronavirus, many contagions, including the Bubonic Plague, syphilis, smallpox and tuberculosis, claimed the lives of hundreds of millions of people worldwide. Ironically, many of these contagions were awarded a ‘rainbow’ of names. Syphilis – a bacterial infection commonly spread by…

Read More